As of June 9, 2025, Alexion Pharmaceuticals Inc (ALXN) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Alexion Pharmaceuticals Inc's Graham Number to Peers
To better understand Alexion Pharmaceuticals Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Alexion Pharmaceuticals Inc (ALXN) | - |
| Biogen Inc (BIIB) | 169.09 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Agios Pharmaceuticals Inc (AGIO) | 83.44 |
| Neurocrine Biosciences Inc (NBIX) | 45.06 |
| Biomarin Pharmaceutical Inc (BMRN) | 38.44 |
Compared to its competitors, Alexion Pharmaceuticals Inc's Graham Number is difficult to compare due to insufficient data.